Home
Hope • Science • Life
Dr. Jonathan Javitt, Founder, Chairman and CEO of NRx Pharmaceuticals, was interviewed again for a broadcast hosted by AdvisorShares.
Interview discusses NRX's latest FDA milestone for its preservative-free ketamine product KETAFREE™, what it means for patients and investors, and how novel therapeutics are shaping the future of medicine.
Dr. Jonathan Javitt, Founder, Chairman and CEO of NRx Pharmaceuticals, was interviewed again for a broadcast hosted by AdvisorShares.
Interview discusses NRX's latest FDA milestone for its preservative-free ketamine product KETAFREE™, what it means for patients and investors, and how novel therapeutics are shaping the future of medicine.
Every 27 seconds someone in the U.S. attempts suicide
11-20% of people with bipolar disorder will die by suicide
0 Approved drugs exist today for suicidal bipolar depression
NRx-101 is the first investigational drug in FDA trials for suicidal bipolar depression, awarded fast track designation, breakthrough therapy designation, and a special protocol agreement by the FDA. Positive Phase 2 data*.
Latest News View all >
-
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Present at Noble Capital Markets October 2025 Emerging Growth Virtual Equity Conference
Monday, October 6, 2025
-
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Re-Files Abbreviated New Drug Application (ANDA) for KETAFREE™, Preservative-Free IV Ketamine
Monday, September 29, 2025
-
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Receives Notification of US Food and Drug Administration Approval of Suitability Petition for NRx’s Proposed Strength of Preservative-Free Ketamine
Wednesday, September 24, 2025
-
HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Complete the Acquisition of Dura Medical; Initial Acquisition in Network of Interventional Psychiatry Clinics
Monday, September 8, 2025
As many as 50% of individuals with bipolar disorder attempt suicide or have serious thoughts of suicide and between 11-20% of those attempt and succumb to suicide.
Source:
Pallaskorpi, et al. “Incidence and predictors of suicide attempts in bipolar I and II disorders: A 5-year follow-up study,” Bipolar Disorders, 2016
“Suicide Attempts and Completions in Patients With Bipolar Disorder,” Psychiatric Times, 2007